Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Change in Receivables (2018 - 2026)

DiaMedica Therapeutics filings provide 9 years of Change in Receivables readings, the most recent being $43000.0 for Q1 2026.

  • Quarterly Change in Receivables rose 152.94% to $43000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $48000.0 through Mar 2026, up 132.88% year-over-year, with the annual reading at $22000.0 for FY2025, 116.54% up from the prior year.
  • Change in Receivables hit $43000.0 in Q1 2026 for DiaMedica Therapeutics, up from -$2000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $131000.0 in Q2 2023 and bottomed at -$101000.0 in Q3 2024.
  • Average Change in Receivables over 5 years is $10058.8, with a median of $7000.0 recorded in 2022.
  • The largest annual shift saw Change in Receivables skyrocketed 1366.67% in 2022 before it tumbled 1050.0% in 2025.
  • DiaMedica Therapeutics' Change in Receivables stood at $7000.0 in 2022, then skyrocketed by 742.86% to $59000.0 in 2023, then crashed by 191.53% to -$54000.0 in 2024, then surged by 96.3% to -$2000.0 in 2025, then soared by 2250.0% to $43000.0 in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Change in Receivables are $43000.0 (Q1 2026), -$2000.0 (Q4 2025), and $99000.0 (Q3 2025).